Pfizer Reports First-Quarter 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Pfizer stock climbs as first quarter earnings, revenue come ahead of estimates
May 1, 2024 6:53 AM EDTPfizer (NYSE: PFE) shares rose 3% in premarket trading Wednesday after the drugmaker reported Q1 earnings and revenue that beat analyst estimates.
Earnings per share (EPS) stood at $0.82, exceeding the consensus estimates of $0.53. Revenue came in at $14.9 billion, also above the consensus projection of $14.04 billion.
Meanwhile, adjusted research and development (R&D) expenses... More
Pfizer (PFE) Tops Q1 EPS by 29c, Beats on Revenue; Offers FY24 Guidance
May 1, 2024 6:46 AM EDTPfizer (NYSE: PFE) reported Q1 EPS of $0.82, $0.29 better than the analyst estimate of $0.53. Revenue for the quarter came in at $14.9 billion versus the consensus estimate of $14.04 billion.
GUIDANCE:
Pfizer sees FY2024 EPS of $2.15-$2.35, versus the consensus of $2.21. Pfizer sees... More
